Verastem, Inc. Additional Paid in Capital, Common Stock
Verastem, Inc. (VSTM) had Additional Paid in Capital, Common Stock of $1.28 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-06
- 2026-06-30: Additional Paid in Capital, Common Stock $1.28B.
- 2026-03-31: Additional Paid in Capital, Common Stock $1.27B.
- 2025-12-31: Additional Paid in Capital, Common Stock $1.22B.
- 2025-09-30: Additional Paid in Capital, Common Stock $1.11B.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $1.28B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.27B 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $1.22B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.11B 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $1.06B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $968.55M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $926.63M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $902.03M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $885.86M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $883.82M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $882.25M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $880.65M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $879.11M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $786.24M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $784.91M 10-K · filed 2024-03-14 | $784.89M 10-K · filed 2023-03-14 |
| 2022-09-30 | $783.61M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $756.63M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $753.54M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $751.22M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $742.84M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $712.59M 10-Q · filed 2021-08-02 | |
| 2021-03-31 | $710.10M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $707.72M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $702.40M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $700.14M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $685.73M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $531.94M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $507.49M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $505.09M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $502.02M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $499.74M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $471.83M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $469.42M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $362.74M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $360.82M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $325.89M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $310.01M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $308.80M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $307.59M 10-K · filed 2018-03-13 | |
| 2015-12-31 | $301.31M 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |